Natural products-friends or foes?

Toxicology Letters

Volumn 236, Issue 3, 2015, Pages 154-167

  Margină, Denisa ^a   Ilie, Mihaela ^a   Grădinaru, Daniela ^a   Androutsopoulos, Vasilis P ^b   Kouretas, Demetrios ^c   Tsatsakis, Aristidis M ^b  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF CRETE   (Greece)

^c UNIVERSITY OF THESSALY   (Greece)

Author keywords

Diet components; Food supplements; Food drug interactions; Toxic outcomes

Indexed keywords

ANTIOXIDANT; CAROTENOID; CURCUMIN; NATURAL PRODUCT; PLANT EXTRACT; POLYPHENOL DERIVATIVE; RESVERATROL; BIOLOGICAL PRODUCT; POLYPHENOL;

ANTIOXIDANT ACTIVITY; DIET SUPPLEMENTATION; DRUG EFFECT; FOOD DRUG INTERACTION; GRAPEFRUIT JUICE; HUMAN; PRIORITY JOURNAL; REVIEW; ANALOGS AND DERIVATIVES; GRAPEFRUIT;

BIOLOGICAL PRODUCTS; CAROTENOIDS; CITRUS PARADISI; CURCUMIN; HUMANS; PLANT EXTRACTS; POLYPHENOLS;

EID: 84930227259     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2015.05.009     Document Type: Review

References (172)

1. Abraham I., El Sayed K., Chen Z.S., Guo H. Current status on marine products with reversal effect on cancer multidrug resistance. Mar. Drugs 2012, 10:2312-2321.
2. Ahn D., Putt D., Kresty L., Stoner G.D., Fromon D., Hollenberg P.F. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes. Carcinogenesis 1996, 17:821-828.
3. Alvarez A.I., Real R., Perez M., Mendoza G., Prieto J.G., Merino G. Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response. J. Pharm. Sci. 2010, 99:598-617.
4. Anauate M.C., Torres L.M., de Mello S.B. Effect of isolated fractions of Harpagophytum procumbens D.C. (Devil's Claw) on COX-1: COX-2 activity and nitric oxide production on whole-blood assay. Phytother. Res. 2010, 24:1365-1369.
5. Androutsopoulos V.P., Spandidos D.A. The flavonoids diosmetin and luteolin exert synergistic cytostatic effects in human hepatoma HepG2 cells via CYP1A-catalyzed metabolism, activation of JNK and ERK and p53/p21 upregulation. J. Nutr. Biochem. 2013, 24:496-504.
6. Androutsopoulos V.P., Tsatsakis A.M. Benzo[a]pyrene sensitizes MCF7 breast cancer cells to induction of G1 arrest by the natural flavonoid eupatorin-5-methyl ether, via activation of cell signalling proteins and CYP1-mediated metabolism. Toxicol. Lett. 2014, 230:304-313.
7. Androutsopoulos V., Arroo R.R., Hall J.F., Surichan S., Potter G.A. Antiproliferative and cytostatic effects of the natural product eupatorin on MDAMB- 468 human breast cancer cells due to CYP1 mediated metabolism. Breast Cancer Res. 2008, 10:R39.
8. Androutsopoulos V.P., Papakyriakou A., Vourloumis D., Tsatsakis A.M., Spandidos D.A. Dietary flavonoids in cancer therapy and prevention: substrates and inhibitors of cytochrome P450CYP1 enzymes. Pharmacol. Ther. 2010, 126(1):9-20.
9. Androutsopoulos V.P., Papakyriakou A., Vourloumis D., Spandidos D.A. Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids. Bioorg. Med. Chem. 2011, 19:2842-2849.
10. Apostolou A., Stagos D., Galitsiou E., Spyrou A., Haroutounian S., Portesis N., Trizoglou I., Wallace Hayes A., Tsatsakis A.M., Kouretas D. Assessment of polyphenolic content antioxidant activity, protection against ROS-induced DNA damage and anticancer activity of Vitis vinifera stem extracts. Food Chem. Toxicol. 2013, 61:60-68.
11. Arroo R.R., Androutsopoulos V., Patel A., Surichan S., Wilsher N., Potter G.A. Phytoestrogens as natural prodrugs in cancer prevention: a novel concept. Phytochem. Rev. 2008, 7:431-443.
12. Awad H.M., Boersma M.G., Vervoort J., Rietjens I.M.C.M. Peroxidase-catalyzed formation of quercetin quinone methide-glutathione adducts. Arch. Biochem. Biophys. 2000, 378:224-233.
13. Awad H.M., Boersma M.G., Boeren S., van der Woude H., van Zanden J., van Bladeren P.J., Vervoort J., Rietjens I.M.C.M. Identification of o-quinone/quinone methide metabolites of quercetin in a cellular in vitro system. FEBS Lett. 2002, 520:30-34.
14. Bailey D.G., Malcolm J., Arnold O., Spence J.D. Grapefruit juice drug interactions. Br. J. Clin. Pharmacol. 1998, 46:101-110.
15. Bailey D.G., Dresser G.K., Leake B.F., Kim R.B. Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. Clin. Pharmacol. Ther. 2007, 81:495-502.
16. Bailey D.G. Fruit juice inhibition of uptake transport: a new type of food-drug interaction. Br. J. Clin. Pharmacol. 2010, 70:645-655.
17. Bamba Y., Yun Y.S., Kunugi A., Inoue H. Compounds isolated from Curcuma aromatica Salisb. inhibit human P450 enzymes. J. Nat. Med. 2011, 65:583-587.
18. Berardini N., Fezer R., Conrad J., Beifuss U., Carle R., Schieber A. Screening of mango (Mangifera indica L.) cultivars for their contents of flavonol O- and xanthone C-glycosides anthocyanins, and pectin. J. Agric. Food Chem. 2005, 53:1563-1570.
19. Bohn T. Dietary factors affecting polyphenol bioavailability. Nutr. Rev. 2014, 72(7):429-452. 10.1111/nure.12114.
20. Boots A.W., Li H., Schins R.P.F., Duffin R., Heemskerk J.W.M., Bast A., Haenen G.R.M.M. The quercetin paradox. Toxicol. Appl. Pharmacol. 2007, 222:89-96.
21. Boots A.W., Guido R.M.M., Haenen A.B. Health effects of quercetin: from antioxidant to nutraceutical. Eur. J. Pharmacol. 2008, 585:325-337.
22. Borska S., Sopel M., Chmielewska M., Zabel M., Dziegiel P. Quercetin as a potential modulator of P-glycoprotein expression and function in cells of human pancreatic carcinoma line resistant to daunorubicin. Molecules 2010, 15:857-870.
23. Bracke M.E., Depypere H.T., Boterberg T., Van Marck V.L., Vennekens K.M., Vanluchene E., Nuytinck M., Serreyn R., Mareel M.M. Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer. J. Natl. Cancer Inst. 1999, 91:354-359. 10.1093/jnci/91.4.354.
24. Cao G., Sofic E., Prior R.L. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic. Biol. Med. 1997, 22:749-760.
25. Cermak R., Landgraf S., Wolffram S. Quercetin glucosides inhibit glucose uptake into brush-border-membrane vesicles of porcine jejunum. Br. J. Nutr. 2004, 91:849-855.
26. Chang T.K., Yeung R.K. Effect of trans-resveratrol on 7-benzyloxy-4- trifluoromethylcoumarin O-dealkylation catalyzed by human recombinant CYP3A4 and CYP3A5. Can. J. Physiol. Pharmacol. 2001, 79:220-226.
27. Chang T.K.H., Chen J., Yeung E.Y.H. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin kaempferol, and quercetin as potent inhibitors of CYP1B1. Toxicol. Appl. Pharmacol. 2006, 213:18-26.
28. Chen Z.H., Hurh Y.J., Na H.K., Kim J.H., Chun Y.J., Kim D.H., Kang K.S., Cho M.H., Surh Y.J. Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells. Carcinogenesis 2004, 25:2005-2013.
29. Chi Y.C., Lin S.P., Hou Y.C. A new herb-drug interaction of Polygonum cuspidatum a resveratrol-rich nutraceutical, with carbamazepine in rats. Toxicol. Appl. Pharmacol. 2012, 263:315-322.
30. Chieli E., Romiti N., Rodeiro I., Garrido G. In vitro effects of Mangifera indica and polyphenols derived on ABCB1/P-glycoprotein activity. Food Chem. Toxicol. 2009, 47:2703-2710.
31. Chieli E., Romiti N., Rodeiro I., Garrido G. In vitro modulation of ABCB1/P-glycoprotein expression by polyphenols from Mangifera indica. Chem. Biol. Interact. 2010, 186:287-294.
32. Cho Y.A., Lee W., Choi J.S. Effects of curcumin on the pharmacokinetics of tamoxifen and its active metabolite 4-hydroxytamoxifen, in rats: possible role of CYP3A4 and P-glycoprotein inhibition by curcumin. Pharmazie 2012, 67:124-130.
33. Choi E.J., Chee K.M., Lee B.H. Anti- and prooxidant effects of chronic quercetin administration in rats. Eur. J. Pharmacol. 2003, 482(1-3):281-285.
34. Choi J.S., Choi H.K., Shin S.C. Enhanced bioavailability of paclitaxel after oral coadministration with flavone in rats. Int. J. Pharm. 2004, 275:165-170.
35. Choi H., Chun Y.S., Shin Y.J., Ye S.K., Kim M.S., Park J.W. Curcumin attenuates cytochrome P450 induction in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin by ROS-dependently degrading AhR and ARNT. Cancer Sci. 2008, 99:2518-2524.
36. Chow H.H., Garland L.L., Hsu C.H., Vining D.R., Chew W.M., Miller J.A., Perloff M., Crowell J.A., Alberts D.S. Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prev. Res. 2010, 3:1168-1175.
37. Chung J.H., Choi D.H., Choi J.S. Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats. Biopharm. Drug Dispos. 2009, 30:90-93.
38. Ciolino H.P., Yeh G.C. Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol. Pharmacol. 1999, 56(4):760-767.
39. D'Alessandro N., Poma P., Montalto G. Multifactorial nature of hepatocellular carcinoma drug resistance: could plant polyphenols be helpful?. World J. Gastroenterol. 2007, 13:2037-2043.
40. De Castro W.V., Mertens-Talcott S., Derendorf H., Butterweck V. Effect of grapefruit juice, naringin, naringenin, and bergamottin on the intestinal carrier-mediated transport of talinolol in rats. J. Agric. Food Chem. 2008, 56:4845-4849.
41. Doodstdar H., Burke M.D., Mayer R.T. Bioflavonoids: selective substrates and inhibitors for cytochrome P450CYP1A and CYP1B1. Toxicology 2000, 144:31-38.
42. Dresser G.K., Bailey D.G., Leake B.F., Schwarz U.I., Dawson P.A., Freeman D.J., Kim R.B. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin. Pharmacol. Ther. 2002, 71:11-20.
43. Dresser G.K., Wacher V., Wong S., Wong H.T., Bailey D.G. Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo. Clin. Pharmacol. Ther. 2002, 72(3):247-255.
44. Dudka J., Jodynis-Liebert J., Korobowicz E., Burdan F., Korobowicz A., Szumilo J., Tokarska E., Klepacz R., Murias M. Activity of NADPH-cytochrome P-450 reductase of the human heart, liver and lungs in the presence of (-)-epigallocatechin gallate, quercetin and resveratrol: an in vitro study. Basic Clin. Pharmacol. Toxicol. 2005, 97:74-79.
45. Edwards R.L., Lyon T., Litwin S.E., Rabovsky A., Symons J.D., Jalili T. Quercetin reduces blood pressure in hypertensive subjects. J. Nutr. 2007, 137:2405-2411.
46. Efferth T., Davey M., Olbrich A., Rucker G., Gebhart E., Davey R. Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug resistant human CCRF-CEM leukemia cells. Blood Cells Mol. Dis. 2002, 28:160-168.
47. Eichhorn T., Efferth T. P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs. J. Ethnopharmacol. 2012, 141:557-570.
48. Estudante M., Morais J.G., Soveral G., Benet L.Z. Intestinal drug transporters: an overview. Adv. Drug Deliv. Rev. 2013, 65:1340-1356.
49. Fraga C.G., Oteiza P.I. Dietary flavonoids: role of (-)-epicatechin and related procyanidins in cell signaling. Free Radic. Biol. Med. 2011, 51:813-823.
50. Fraga C.G., Galleano M., Verstraeten S.V., Oteiza P.I. Basic biochemical mechanisms behind the health benefits of polyphenols. Mol. Aspects Med. 2010, 31:435-445.
51. Fukumoto K., Kobayashi T., Tachibana K., Kato R., Tanaka K., Komamura K., Kamakura S., Kitakaze M., Ueno K. Effect of amiodarone on the serum concentration/dose ratio of metoprolol in patients with cardiac arrhythmia. Drug Metab. Pharmacokinet. 2006, 21:501-505.
52. Galati G., O'Brien P.J. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radic. Biol. Med. 2004, 37:287-303.
53. Galati G., Sabzevari O., Wilson J.X., O'Brien P.J. Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics. Toxicology 2002, 177:91-104.
54. Garrido-Garrido G., Martinez-Sanchez G., Pardo-Andreu G., Garcia-Rivera D., Hernandez-Casana P., Rodeiro-Guerra I., Guevara-Garcia M., Delgado-Hernandez R., Nunez-Selles A.J. Recent advances in the research and development of an aqueous stem bark extract obtained from Mangifera indica L. Recent Developments in Medicinal Plant Research 2007, 169-192. Research Signpost, Trivandrum, India. A. Capasso (Ed.).
55. Georgiev M.I., Alipieva K., Orhan I.E. Cholinesterases inhibitory and antioxidant activities of Harpagophytum procumbens from in vitro systems. Phytother. Res. 2012, 26:313-316.
56. Goey A.K., Meijerman I., Rosing H., Marchetti S., Mergui-Roelvink M., Keessen M., Burgers J.A., Beijnen J.H., Schellens J.H. The effect of St John's wort on the pharmacokinetics of docetaxel. Clin. Pharmacokinet. 2014, 53:103-110.
57. Golden E.B., Lam P.Y., Kardosh A., Gaffney K.J., Cadenas E., Louie S.G., Petasis N.A., Chen T.C., Schönthal A.H. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood 2009, 113:5927-5937.
58. Goosen T.C., Cillié D., Bailey D.G., Yu C., He K., Hollenberg P.F., Woster P.M., Cohen L., Williams J.A., Rheeders M., Dijkstra H.P. Bergamottin contribution to the grapefruit juice-felodipine interaction and disposition in humans. Clin. Pharmacol. Ther. 2004, 76(6):607-617.
59. Gorman G.S., Coward L., Darby A., Rasberry B. Effects of herbal supplements on the bioactivation of chemotherapeutic agents. J. Pharm. Pharmacol. 2013, 65:1014-1025.
60. Grant L., McBean D.E., Fyfe L., Warnock A.M. A review of the biological and potential therapeutic actions of Harpagophytum procumbens. Phytother. Res. 2007, 21:199-209.
61. The Photochemistry of Carotenoids 1999, 363-369. Kluwer Acad. Publ., Dordrecht/Boston/London. W.I. Gruszecki, H.A. Frank, A.J. Young, G. Britton (Eds.).
62. Gyémánt N., Tanaka T., Molnár P., Deli J., Mándoky J., Molnár J. Reversal of multidrug resistance of cancer cells in vitro: modification of drug resistance by selected carotenoids. Anticancer Res. 2006, 26:367-374.
63. Halliwell B., Gutterridge J.M.C. The antioxidants of human extracellular fluids. Arch. Biochem. Biophys. 1990, 280:1-8.
64. Hanasaki Y., Ogawa S., Fukui S. The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Radic. Biol. Med. 1994, 16:845-850.
65. Harwood M., Danielewska-Nikiel B., Borzelleca J.F., Flamm G.W., Williams G.M., Lines T.C. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem. Toxicol. 2007, 45:2179-2205.
66. Heim K.E., Tagliaferro A.R., Bobilya D.J. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J. Nutr. Biochem. 2002, 13:572-584.
67. Hendrich A.B., Michalak K. Lipids as a target for drugs modulating multidrug resistance of cancer cells. Curr. Drug Targets 2003, 4:23-30.
68. Hodek P., Trefil P., Stiborová M. Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem. Biol. Interact. 2002, 139:1-21.
69. Huang F., Wu X.N., Chen J., Wang W.X., Lu Z.F. Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells. Exp. Ther. Med. 2014, 7:1611-1616.
70. Imai S., Fukui M., Ozasa N., Ozeki T., Kurokawa M., Komatsu T., Kajiyama S. Eating vegetables before carbohydrates improves postprandial glucose excursions. Diabet. Med. 2013, 30:370-372.
71. Ingolfsson H.I., Koeppe R.E., Andersen O.S. Curcumin is a modulator of bilayer material properties. Biochemistry 2007, 46:10384-10391.
72. Jáuregui-Garrido B., Jáuregui-Lobera I. Interactions between antihypertensive drugs and food. Nutr. Hosp. 2012, 27:1866-1875.
73. Jacobs H., Moalin M., Bast A., van der Vijgh W.J.F., Haenen G.R.M.M. An essential difference between the flavonoids monoHER and quercetin in their interplay with the endogenous antioxidant network. PLoS ONE 2010, 5(11):e13880. 10.1371/journal.pone.0013880.
74. Jang E.H., Choi J.Y., Park C.S., Lee S.K., Kim C.E., Park H.J., Kang J.S., Lee J.W., Kang J.H. Effects of green tea extract administration on the pharmacokinetics of clozapine in rats. J. Pharm. Pharmacol. 2005, 57:311-316.
75. Jendželovská Z., Jendželovský R., Hiovská L., Kova J., Mikeš J., Fedoročko P. Single pre-treatment with hypericin, a St. John's wort secondary metabolite, attenuates cisplatin- and mitoxantrone-induced cell death in A2780, A2780cis and HL-60 cells. Toxicol. In Vitro 2014, 28:1259-1273.
76. Johnson J.L., Gonzalez de Mejia E. Interactions between dietary flavonoids apigenin or luteolin and chemotherapeutic drugs to potentiate anti-proliferative effect on human pancreatic cancer cells, in vitro. Food Chem. Toxicol. 2013, 60:83-91.
77. Johnston K., Sharp P., Clifford M., Morgan L. Dietary polyphenols decrease glucose uptake by human intestinal Caco-2 cells. FEBS Lett. 2005, 579:1653-1657.
78. Ju Y.H., Doerge D.R., Allred K.F., Allred C.D., Helferich W.G. Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice. Cancer Res. 2002, 62:2474-2477.
79. Karewicza A., Bielska D., Gzyl-Malcher B., Kepczynski M., Lach R., Nowakowska M. Interaction of curcumin with lipid monolayers and liposomal bilayers. Colloids Surf. B: Biointerfaces 2011, 88:231-239.
80. Kim H., Kim K.B., Ku H.Y., Park S.J., Choi H., Moon J.K., Park B.S., Kim J.H., Yea S.S., Lee C.H., Lee H.S., Shin J.G., Liu K.H. Identification and characterization of potent CYP2B6 inhibitors in woohwangcheongsimwon suspension, an herbal preparation used in the treatment and prevention of apoplexy in Korea and China. Drug Metab. Dispos. 2008, 36:1010-1015.
81. Kim J.H., Chen C., Tony Kong A.N. Resveratrol inhibits genistein-induced multi-drug resistance protein 2 (MRP2) expression in HepG2 cells. Arch. Biochem. Biophys. 2011, 512:160-166.
82. Kim T.H., Shin Y.J., Won A.J., Lee B.M., Choi W.S., Jung J.H., Chung H.Y., Kim H.S. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin. Biochim. Biophys. Acta 2014, 1840:615-625.
83. Kitagawa S. Inhibitory effects of polyphenols on P-glycoprotein-mediated transport. Biol. Pharm. Bull. 2006, 29:1-6.
84. Koga N., Ohta C., Kato Y., Haragushi K., Endo T., Ogawa K., Ohta H., Yano M. In vitro metabolism of nobiletin, a polymethoxy-flavonoid, by human liver microsomes and cytochrome P450. Xenobiotica 2011, 41(11):927-933.
85. Kuhlmann M.K., Horsch E., Burkhardt G., Wagner M., Köhler H. Reduction of cisplatin toxicity in cultured renal tubular cells by the bioflavonoid quercetin. Arch. Toxicol. 1998, 72(8):536-540.
86. Lamson D.W., Brignall M.S. Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern. Med. Rev. 1999, 4:304-329.
87. Lamson D.W., Brignall M.S. Antioxidants and cancer therapy II: quick reference guide. Altern. Med. Rev. 2000, 5:152-163.
88. Lau W.C., Welch T.D., Shields T., Rubenfire M., Tantry U.S., Gurbel P.A. The effect of St John's wort on the pharmacodynamic response of clopidogrel in hyporesponsive volunteers and patients: increased platelet inhibition by enhancement of CYP3A4 metabolic activity. J. Cardiovasc. Pharmacol. 2011, 57:86-93.
89. Laughton M.J., Halliwell B., Evans P.J., Robin J., Hoult S. Antioxidant and pro-oxidant actions of the plant phenolics quercetin gossypol and myricetin: effects of lipid peroxidation, hydroxyl radical generation and bleomycin-dependent damage to DNA. Biochem. Pharmacol. 1989, 38:2859-2864.
90. Li X., Choi J.S. Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats. Int. J. Pharm. 2007, 337(1-2):188-193.
91. Li C., Choi J.S. Effects of epigallocatechin gallate on the bioavailability and pharmacokinetics of diltiazem in rats. Pharmazie 2008, 63:815-818.
92. Li P., Callery P.S., Gan L.S., Balani S.K. Esterase inhibition by grapefruit juice flavonoids leading to a new drug interaction. Drug Metab. Dispos. 2007, 35:1203-1208.
93. Li J., Godecke T., Chen S.N., Imai A., Lankin D.C., Farnsworth N.R., Pauli G.F., van Breemen R.B., Nikolic D. In vitro metabolic interactions between black cohosh (Cimicifuga racemosa) and tamoxifen via inhibition of cytochromes P450 2D6 and 3A4. Xenobiotica 2011, 41:1021-1030.
94. Lu J.J., Cai Y.J., Ding J. The short-time treatment with curcumin sufficiently decreases cell viability: induces apoptosis and copper enhances these effects in multidrug-resistant K562/A02 cells. Mol. Cell. Biochem. 2012, 360:253-260.
95. Lunde I., Bremer S., Midtvedkt K., Mohebi B., Dahl M., Bergan S., Asberg A., Christensen H. The influence of CYP3A: PPARA and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant patients. Eur. J. Clin. Pharmacol. 2014, 70:685-693.
96. Mancuso C., Barone E. Therapeutic use of tea derivatives: all that glitters is not gold. Blood 2009, 114:2359-2360.
97. Marín L., Miguélez E.M., Villar C.J., Lombó F. Bioavailability of dietary polyphenols and gut microbiota metabolism: antimicrobial properties. Biomed. Res. Int. 2015, arxiv:/905215, 10.1155/2015/905215.
98. Margina D., Gradinaru D., Manda G., Neagoe I., Ilie M. Membranar effects exerted in vitro by polyphenols -quercetin, epigallocatechin gallate and curcumin- on HUVEC and Jurkat cells relevant for diabetes mellitus. Food Chem. Toxicol. 2013, 61:86-93.
99. Miao M., Jiang H., Jiang B., Zhang T., Cui S.W., Jin Z. Phytonutrients for controlling starch digestion: evaluation of grape skin extract. Food Chem. 2014, 145:205-211.
100. Mukherjee P.K., Ponnusankar S., Pandit S., Hazam P.K., Ahmmed M., Mukherjee K. Botanicals as medicinal food and their effects on drug metabolizing enzymes. Food Chem. Toxicol. 2011, 49:3142-3153.
101. Murota K., Terao J. Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch. Biochem. Biophys. 2003, 417:12-17.
102. Muto S., Fujita K., Yamazaki Y., Kamataki T. Inhibition by green tea catechins ofmetabolic activation of procarcinogens by human cytochrome P450. Mutat. Res. 2001, 479:197-206.
103. Nabekura T., Kamiyama S., Kitagawa S. Effects of dietary chemopreventive phytochemicals on P-glycoprotein function. Biochem. Biophys. Res. Commun. 2005, 327:866-870.
104. Nabekura T. Overcoming multidrug resistance in human cancer cells by natural compounds. Toxins 2010, 2:1207-1224.
105. Nagai M., Fukamachi T., Tsujimoto M., Ogura K., Hiratsuka A., Ohtani H., Hori S., Sawada Y. Inhibitory effects of herbal extracts on the activity of human sulfotransferase isoform sulfotransferase 1A3 (SULT1A3). Biol. Pharm. Bull. 2009, 32:105-109.
106. Nakagawa H.K., Hasumi J.T., Nagai K., Wachi M. Generation of hydroxide peroxide primarily contributes to the induction of Fe(II)-dependent apoptosis in Jurkat cells by (-)-epigallocatechin-3-gallate. Carcinogenesis 2004, 25:1567-1574.
107. Nishimuta H., Ohtani H., Tsujimoto M., Ogura K., Hiratsuka A., Sawada Y. Inhibitory effects of various beverages on human recombinant sulfotransferase isoforms SULT1A1 and SULT1A3. Biopharm. Drug Dispos. 2007, 28:491-500.
108. Nunez-Selles A.J., Delgado-Hernandez R., Garrido-Garrido G., Garcia-Rivera D., Guevara-Garcia M., Pardo-Andreu G.L. The paradox of natural products as pharmaceuticals. Experimental evidences of a mango stem bark extract. Pharmacol. Res. 2007, 55:351-358.
109. Ofer M., Wolffram S., Koggel A., Spahn-Langguth H., Langguth P. Modulation of drug transport by selected flavonoids: Involvement of P-gp and OCT?. Eur. J. Pharm. Sci. 2005, 25:263-271.
110. Ohnishi A., Ohtani H., Sawada Y. Major determinant factors of the extent of interaction between grapefruit juice and calcium channel antagonists. Br. J. Clin. Pharmacol. 2006, 62(2):196-199.
111. Owira P.M., Ojewole J.A. The grapefruit: an old wine in a new glass? Metabolic and cardiovascular perspectives. Cardiovasc. J. Afr. 2010, 21:280-285.
112. Pal D., Mitra A.K. MDR- and CYP3A4-mediated drug-herbal interactions. Life Sci. 2006, 78:2131-2145.
113. Panchagnula R., Bansal T., Varma M.V., Kaul C.L. Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux. Pharmazie 2005, 60(12):922-927.
114. Park D., Jeon J.H., Shin S., Joo S.S., Kang D.H., Moon S.H., Jang M.J., Cho Y.M., Kim J.W., Ji H.J., Ahn B., Oh K.W., Kim Y.B. Green tea extract increases cyclophosphamide induced teratogenesis by modulating the expression of cytochrome P-450 mRNA. Reprod. Toxicol. 2009, 27:79-84.
115. Parker R.S. Absorption: metabolism and transport of carotenoids. FASEB J. 1996, 10:185-197.
116. Piao Y.J., Choi J.S. Enhanced bioavailability of verapamil after oral administration with hesperidin in rats. Arch. Pharm. Res. 2008, 31:518-522.
117. Piver B., Berthou F., Dreano Y., Lucas D. Inhibition of CYP3A: CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components. Toxicol. Lett. 2001, 125:83-91.
118. Procházková D., Boušová I., Wilhelmová N. Antioxidant and prooxidant properties of flavonoids. Fitoterapia 2011, 82:513-523.
119. Qi J., Chen J.J., Cheng Z.H., Zhou J.H., Yu B.Y., Qiu S.X. Iridoid glycosides from Harpagophytum procumbens D.C. (Devil's Claw). Phytochemistry 2006, 67:1372-1377.
120. Rahimi R., Abdollahi M. An update on the ability of St. John's wort to affect the metabolism of other drugs. Expert Opin. Drug Metab. Toxicol. 2012, 8:691-708.
121. Rangan G.K., Wang Y., Harris D.C.H. Dietary quercetin augments activator protein-1 and does not reduce nuclear facto-κB in the renal cortex of rats with established chronic glomerular disease. Nephron 2002, 90:313-319.
122. Ravishankar D., Rajora A.K., Greco F., Osborn H.M.I. Flavonoids as prospective compounds for anti-cancer therapy. Int. J. Biochem. Cell Biol. 2013, 45:2821-2831.
123. Reddy P., Ellington D., Zhu Y., Zdrojewski I., Parent S.J., Harmatz J.S., Derendorf H., Greenblatt D.J., Browne K. Serum concentrations and clinical effects of atorvastatin in patients taking grapefruit juice daily. Br. J. Clin. Pharmacol. 2011, 72(3):434-441.
124. Ren W., Qiao Z., Wang H., Zhu L., Zhang L. Flavonoids: promising anticancer agents. Med. Res. Rev. 2003, 23:519-534.
125. Revel A., Raanani H., Younglai E., Xu J., Rogers I., Han R., Savouret J.F., Casper R.F. Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. J. Appl. Toxicol. 2003, 23:255-261.
126. Rochat B., Morsman J.M., Murray G.I., Figg W.D., McLeod H.L. Human CYP1B1 and anticancer agent metabolism: mechanims for tumor-specific drug inactivation?. J. Pharmacol. Exp. Ther. 2001, 296(2):537-541.
127. Rodeiro I., Donato M.T., Lahoz A., Garrido G., Delgado R., Gomez-Lechon M.J. Interactions of polyphenols with the P450 system: possible implications on human therapeutics. Mini Rev. Med. Chem. 2008, 8:97-106.
128. Rodeiro I., Donato M.T., Lahoz A., Gonzalez-Lavaut J.A., Laguna A., Castell J.V., Delgado R., Gomez-Lechon M.J. Modulation of P450 enzymes by Cuban natural products rich in polyphenolic compounds in rat hepatocytes. Chem. Biol. Interact. 2008, 172:1-10.
129. Rodeiro I., José Gómez-Lechón M., Perez G., Hernandez I., Herrera J.A., Delgado R., Castell J.V., Teresa Donato M. Mangifera indica L: extract and mangiferin modulate cytochrome P450 and UDP-glucuronosyltransferase enzymes in primary cultures of human hepatocytes. Phytother. Res. 2013, 27:745-752.
130. Romiti N., Tramonti G., Corti A., Chieli E. Effects of Devil's Claw (Harpagophytum procumbens) on the multidrug transporter ABCB1/P-glycoprotein. Phytomedicine 2009, 16:1095-1100.
131. Sainz R.M., Mayo J.C., Tan D.X., Lopez-Burillo S., Natarajan M., Reiter R.J. Antioxidant activity of melatonin in Chinese hamster ovarian cells: changes in cellular proliferation and differentiation. Biochem. Biophys. Res. Commun. 2003, 302:625-634.
132. Sak K. Chemotherapy and dietary phytochemical agents. Chemother. Res. Pract. 2012, arxiv:/282570, 10.1155/2012/282570.
133. Scambia G., Ranelletti F.O., Panici P.B., et al. Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemother. Pharmacol. 1994, 34(6):459-464.
134. Scholz S., Williamson G. Interactions affecting the bioavailability of dietary polyphenols in vivo. Int. J. Vitam. Nutr. Res. 2007, 77(3):224-235.
135. Shah J.J., Kuhn D.J., Orlowski R.Z. Bortezomib and EGCG: no green tea for you?. Blood 2009, 113:5695-5696.
136. Shirasaka Y., Kuraoka E., Spahn-Langguth H., Nakanishi T., Langguth P., Tamai I. Species difference in the effect of grapefruit juice on intestinal absorption of talinolol between human and rat. J. Pharmacol. Exp. Ther. 2010, 332:181-189.
137. Shirasaka Y., Shichiri M., Murata Y., Mori T., Nakanishi T., Tamai I. Long-lasting inhibitory effect of apple and orange juices but not grapefruit juice, on OATP2B1-mediated drug absorption. Drug Metab. Dispos. 2013, 41:615-621.
138. Smith C., Mitchinson M.J., Arudma O.I., Halliwell B. Stimulation of lipid peroxidation and hydroxyl radical generation by the contents of human atherosclerotic lesions. Biochem. J. 1992, 286:901-905.
139. Socaciu C., Bojarski P., Aberle L., Diehl H.A. Different ways to insert carotenoids into liposomes affect structure and dynamics of the lipid bilayer differently. Biophys. Chem. 2002, 99:1-15.
140. Socaciu C., Jessel R., Diehl H.A. Competitive carotenoid and cholesterol incorporation into liposomes: effects on membrane phase transition, fluidity, polarity and anisotropy. Chem. Phys. Lipids 2002, 106:79-88.
141. Sousa M.C., Braga R.C., Cintra B.A.S., de Oliveira V., Andrade C.H. In silico metabolism studies of dietary flavonoids by CYP1A2 and CYP2C9. Food Res. Int. 2013, 50:102-110.
142. Spanou C.I., Veskoukis A.S., Stagos D., Liadaki K., Aligiannis N., Angelis A., Skaltsounis A.L., Anastasiadi M., Haroutounian S.A., Kouretas D. Effects of Greek legume plant extracts on xanthine oxidase, catalase and superoxide dismutase activities. J. Physiol. Biochem. 2012, 68(1):37-45.
143. Stagos D., Portesis N., Spanou C., Mossialos D., Aligiannis N., Chaita E., Panagoulis C., Reri E., Skaltsounis L., Tsatsakis A.M., Kouretas D. Correlation of total polyphenolic content with antioxidant and antibacterial activity of 24 extracts from Greek domestic Lamiaceae species. Food Chem. Toxicol. 2012, 50(11):4115-4124.
144. Sun Y., Lee C.C., Hung W.C., Chen F.Y., Lee M.T., Huang H.W. The bound states of amphipathic drugs in lipid bilayers: study of curcumin. Biophys. J. 2008, 95:2318-2324.
145. Surh Y.S., Lee S.S. Capsaicin a double-edged sword: toxicity, metabolism and chemopreventive potential. Life Sci. 1995, 56:1845-1855.
146. Szaefer H., Cichocki M., Brauze D., Baer-Dubowska W. Alteration in phase I and II enzyme activities and polycyclic aromatic hydrocarbons-DNA adduct formation by plant phenolics in mouse epidermis. Nutr. Cancer 2004, 48:70-77.
147. Szakacs G., Paterson J.K., Ludwig J.A., Booth-Genthe C., Gottesman M.M. Targeting multidrug resistance in cancer. Nat. Rev. Drug Discov. 2006, 5:219-234.
148. Tang X.Q., Bi H., Feng J.Q., Cao J.G. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR. Acta Pharmacol. Sin. 2005, 26:1009-1016.
149. Tiwari A.K. Revisiting Vegetables to combat modern epidemic of imbalanced glucose homeostasis. Pharmacogn. Mag. 2014, 10(Suppl. 2):S207-213.
150. Tribolo S., Lodi F., Connor C., Suri S., Wilson V.G., Taylor M.A., Needs P.A., Kroon P.A., Hughes D.A. Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells. Atherosclerosis 2008, 197:50-56.
151. Ulbricht C., Chao W., Costa D., Rusie-Seamon E., Weissner W., Woods J. Clinical evidence of herb-drug interactions: a systematic review by the natural standard research collaboration. Curr. Drug Metab. 2008, 9:1063-1120.
152. Unger M., Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun. Mass Spectrom. 2004, 18:2273-2281.
153. Uno T., Yasui-Furukori N. Effect of grapefruit in relation to human pharmacokinetic study. Curr. Clin. Pharmacol. 2006, 1:157-161.
154. Von Moltke L.L., Weemhoff J.L., Bedir E., Khan I.A., Harmatz J.S., Goldman P., Greenlatt D.J. Inhibition of human cytochrome P450 by components of Ginkgo biloba. J. Pharm. Pharmacol. 2004, 56:1039-1044.
155. Walle T., Ta N., Kawamori T., Wen X., Tsuji P.A., Walle U.K. Cancer chemopreventive properties of orally bioavailable flavonoids-methylated versus unmethylated flavones. Biochem. Pharmacol. 2007, 73:1288-1296.
156. Wang H., Peng D., Xie J. Ginseng leaf-stem: bioactive constituents and pharmacological functions. Chin. Med. 2009, 4:20-27.
157. Wanwimolruk S., Wong K., Wanwimolruk P. Variable inhibitory effect of different brands of commercial herbal supplements on human cytochrome P-450CYP3A4. Drug Metabol. Drug Interact. 2009, 24:17-35.
158. Warnock M., McBean D., Suter A., Tan J., Whittaker P. Effectiveness and safety of Devil's Claw tablets in patients with general rheumatic disorders. Phytother. Res. 2007, 21:1228-1233.
159. Welsch C.A., Lachance P.A., Wasserman B.P. Dietary phenolic compounds: inhibition of Na+-dependent d-glucose uptake in rat intestinal brush border membrane vesicles. J. Nutr. 1989, 119:1698-1704.
160. Wen X., Walle T. Methylated flavonoids have greatly improved intestinal absorption and metabolic stability. Drug Metab. Dispos. 2006, 34:1786-1792.
161. Weng C.J., Yen G.C. Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids monophenol, polyphenol, and their derivatives. Cancer Treat. Rev. 2012, 38:76-87.
162. Wilms L.C., Kleinjans J.C., Moonen E.J., Briedé J.J. Discriminative protection against hydroxyl and superoxide anion radicals by quercetin in human leucocytes in vitro. Toxicol. In Vitro 2008, 22:301-307.
163. Winterbone M.S., Tribolo S., Needs P.W., Kroon P.A., Hughes D.A. Physiologically relevant metabolites of quercetin have no effect on adhesion molecule or chemokine expression in human vascular smooth muscle cells. Atherosclerosis 2009, 202:431-438.
164. Xiao J., Hogger P. Dietary polyphenols and type 2 diabetes: current insights and future. Curr. Med. Chem. 2014, 22(1):23-38.
165. Ye L.H., Kong L.T., Xiao B.X., Wang Q., He X.X., Cao F.R., Chang Q. Simultaneous determination of the activities of five major cytochrome P450 enzymes by an in vitro cocktail method coupled with LC-MS/MS assay. Chin. J. Pharmacovigilance 2013, 10:263-268.
166. Ye L.H., He X.X., Kong L.T., Liao Y.H., Pan R.L., Xiao B.X., Liu X.M., Chang Q. Identification and characterization of potent CYP2D6 inhibitors in lotus leaves. J. Ethnopharmacol. 2014, 153:190-196.
167. Yen G.C., Duh P.D., Tsai H.L., Huang S.L. Pro-oxidative properties of flavonoids in human lymphocytes. Biosci. Biotechnol. Biochem. 2003, 67:1215-1222.
168. Yueh M.F., Kawahara M., Raucy J. Cell-based high-throughput bioassays to assess induction and inhibition of CYP1A enzymes. Toxicol. In Vitro 2005, 19:275-287.
169. Zhang Q.H., Wu C.F., Duan L., Yang J.Y. Protective effects of total saponins from stem and leaf of Panax ginseng against cyclophosphamide-induced genotoxicity and apoptosis in mouse bone marrow cells and peripheral lymphocyte cells. Food Chem. Toxicol. 2008, 46(1):293-302.
170. Zhang J., Zhang T., Ti X., Shi J., Wu C., Ren X., Yin H. Curcumin promotes apoptosis in A549/DDP multidrug-resistant human lung adenocarcinoma cells through an miRNA signaling pathway. Biochem. Biophys. Res. Commun. 2010, 399:1-6.
171. Zhou S., Gao Y., Jiang W., Huang M., Xu A., Paxton J.W. Interactions of herbs with cytochrome P450. Drug Metab. Rev. 2003, 35:35-98.
172. Zhou S.F., Zhou Z.W., Li C.G., Chen X., Yu X., Xue C.C., Herington A. Identification of drugs that interact with herbs in drug development. Drug Discov. Today 2007, 12:664-673.